Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

Procter & Gamble To Jump Over 16%? Here Are 5 Other Price Target Changes For Monday

Published 21/11/2022, 12:50
Updated 21/11/2022, 14:10
© Reuters.  Procter & Gamble To Jump Over 16%? Here Are 5 Other Price Target Changes For Monday

Benzinga -

  • Raymond James boosted The Procter & Gamble Company (NYSE: PG) price target from $155 to $165. . Raymond James analyst Olivia Tong maintained an Outperform rating on the stock. Procter & Gamble shares fell 0.2% to $142.24 in pre-market trading.
  • Citigroup (NYSE:C) cut the price target on Globant S.A. (NYSE: GLOB) from $270 to $225. Citigroup analyst Peter Christiansen maintained a Buy rating on the stock. Select Energy Services shares fell 0.8% to $172.95 in pre-market trading.
  • HC Wainwright & Co. raised Immunocore Holdings plc (NASDAQ: IMCR) price target from $80 to $90. HC Wainwright & Co. analyst Patrick Trucchio maintained a Buy rating on the stock. Immunocore Holdings shares fell 0.1% to close at $64.21 on Friday.
  • Needham raised Avadel Pharmaceuticals plc (NASDAQ: AVDL) price target from $8 to $9. M Needham analyst Ami Fadia maintained a Buy rating on the stock. Avadel Pharmaceuticals rose 0.1% to $8.04 in pre-market trading.
  • HC Wainwright & Co. cut TCR2 Therapeutics Inc. (NASDAQ: TCRR) price target from $14 to $13. HC Wainwright & Co. analyst Robert Burns maintained a Buy rating on the stock. TCR2 Therapeutics shares fell 1.5% to close at $1.31 on Friday.
  • Goldman Sachs (NYSE:GS) boosted Canadian Natural Resources Limited (NYSE: CNQ) price target from $62 to $69. Goldman Sachs analyst Neil Mehta upgraded the stock from Neutral to Buy. Canadian Natural Resources shares fell 0.5% to $59.42 in pre-market trading.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.